Cure My Disease

Don't miss your cure!

 Log in / Sign up

New shingles shot shows promise in Mid-Stage trial

NCT ID NCT07481604

Not yet recruiting Prevention Sponsor: CHA Vaccine Institute Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new shingles vaccine in 135 healthy adults aged 50 and older. Researchers will compare the immune response and safety of the new vaccine against an existing one to find the best dose. The goal is to prevent shingles, a painful rash caused by the chickenpox virus.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HERPES ZOSTER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chickenpox herpes zoster prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HERPES ZOSTER

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CHA Bundang Medical Center

    Seongnam-si, Gyeonggi-do, South Korea

    Contact

  • Chung-Ang University Hospital

    Seoul, Seoul, South Korea

    Contact

  • Ewha Womans University Seoul Hospital

    Seoul, Seoul, South Korea

    Contact

  • Jeonbuk National University Hospital

    Jeonju, Jeollabuk-do, South Korea

    Contact

  • Kyungpook National University Chilgok Hospital

    Daegu, Daegu, South Korea

    Contact

  • The Catholic University of Korea Eunpyeong St. Mary's Hospital

    Seoul, Seoul, 03312, South Korea

    Contact

  • Yongin Severance Hospital, Yonsei University Health System

    Yongin, Gyeonggi-do, South Korea

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.